Published in Exp Eye Res on March 11, 2009
The role of fatty acid β-oxidation in lymphangiogenesis. Nature (2016) 2.04
Effects of topical and subconjunctival bevacizumab in high-risk corneal transplant survival. Invest Ophthalmol Vis Sci (2009) 1.18
Digging deeper into lymphatic vessel formation in vitro and in vivo. BMC Cell Biol (2011) 0.82
Does plasminogen activator inhibitor-1 drive lymphangiogenesis? PLoS One (2010) 0.80
Synergism between vascular endothelial growth factor and placental growth factor contributes to angiogenesis and plasma extravasation in pathological conditions. Nat Med (2001) 6.73
Absence of host plasminogen activator inhibitor 1 prevents cancer invasion and vascularization. Nat Med (1998) 2.54
Regulation of vimentin by SIP1 in human epithelial breast tumor cells. Oncogene (2006) 2.09
In vivo evidence that the stromelysin-3 metalloproteinase contributes in a paracrine manner to epithelial cell malignancy. J Cell Biol (1998) 1.95
The plasminogen activator inhibitor PAI-1 controls in vivo tumor vascularization by interaction with proteases, not vitronectin. Implications for antiangiogenic strategies. J Cell Biol (2001) 1.94
Robot-assisted laparoscopic nephron sparing surgery for tumors over 4 cm: operative results and preliminary oncologic outcomes from a multicentre French study. Eur J Surg Oncol (2013) 1.53
CMV infection in the donor and increased kidney graft loss: impact of full HLA-I mismatch and posttransplantation CD8(+) cell reduction. Am J Transplant (2013) 1.40
The effect of colic on oxygen extraction in horses. Vet J (2007) 1.39
A dynamic in vivo model of epithelial-to-mesenchymal transitions in circulating tumor cells and metastases of breast cancer. Oncogene (2011) 1.38
MiR-210 promotes a hypoxic phenotype and increases radioresistance in human lung cancer cell lines. Cell Death Dis (2013) 1.37
MMP-2- and MMP-9-linked gelatinolytic activity in the sputum from patients with asthma and chronic obstructive pulmonary disease. Int Arch Allergy Immunol (2000) 1.33
Improved quantification of angiogenesis in the rat aortic ring assay. Angiogenesis (2001) 1.29
Influence of plasminogen activator inhibitor type 1 on choroidal neovascularization. FASEB J (2001) 1.29
Down-regulation of vascular endothelial growth factor by tissue inhibitor of metalloproteinase-2: effect on in vivo mammary tumor growth and angiogenesis. Cancer Res (2001) 1.18
High levels of TIMP-2 correlate with adverse prognosis in breast cancer. Int J Cancer (2000) 1.16
Presence of oestrogen receptor type beta in human retina. Br J Ophthalmol (2001) 1.15
Adverse obstetrical outcomes after treatment of precancerous cervical lesions: a Belgian multicentre study. BJOG (2012) 1.14
Expression of a disintegrin and metalloprotease (ADAM and ADAMTS) enzymes in human non-small-cell lung carcinomas (NSCLC). Br J Cancer (2006) 1.11
Role of plasminogen activator-plasmin system in tumor angiogenesis. Cell Mol Life Sci (2003) 1.10
Assay of matrix metalloproteinases types 1, 2, 3 and 9 in breast cancer. Br J Cancer (1998) 1.07
Fetal growth restriction: a workshop report. Placenta (2004) 1.03
Inhibition of matrix metalloproteinase 2 maturation and HT1080 invasiveness by a synthetic furin inhibitor. FEBS Lett (1998) 1.03
Stromelysin-3: a paradigm for stroma-derived factors implicated in carcinoma progression. Crit Rev Oncol Hematol (1997) 1.03
Quality assurance in radiotherapy: the importance of medical physics staffing levels. Recommendations from an ESTRO/EFOMP joint task group. Radiother Oncol (1996) 1.03
Higher sensitivity of Adamts12-deficient mice to tumor growth and angiogenesis. Oncogene (2010) 1.02
Membrane type 1 matrix metalloproteinase-associated degradation of tissue inhibitor of metalloproteinase 2 in human tumor cell lines. J Biol Chem (2000) 1.02
Induction of endothelial cell apoptosis by solid tumor cells. Exp Cell Res (1998) 1.01
The role of imaging in staging and monitoring testicular cancer. Diagn Interv Imaging (2012) 1.01
Type IV collagen induces matrix metalloproteinase 2 activation in HT1080 fibrosarcoma cells. Exp Cell Res (2000) 1.00
Matrix metalloproteinases and TIMP-1 production by peripheral blood granulocytes from COPD patients and asthmatics. Allergy (2001) 0.99
Induction of SPARC by VEGF in human vascular endothelial cells. Biochem Biophys Res Commun (2001) 0.99
MT1-MMP protects breast carcinoma cells against type I collagen-induced apoptosis. Oncogene (2011) 0.98
Macrophage migration inhibitory factor (MIF) expression in human glioblastomas correlates with vascular endothelial growth factor (VEGF) expression. Neuropathol Appl Neurobiol (2002) 0.97
Esophageal cancer: determination of internal target volume for conformal radiotherapy. Radiother Oncol (2006) 0.96
Right shift of the oxyhemoglobin dissociation curve in acute respiratory distress syndrome. Pathol Biol (Paris) (1997) 0.94
Human chorionic gonadotropin and growth factors at the embryonic-endometrial interface control leukemia inhibitory factor (LIF) and interleukin 6 (IL-6) secretion by human endometrial epithelium. Hum Reprod (2004) 0.94
Two genes contribute to different extents to the heme oxygenase enzyme activity measured in cultured human skin fibroblasts and keratinocytes: implications for protection against oxidant stress. Photochem Photobiol (1995) 0.93
Alteration of interendothelial adherens junctions following tumor cell-endothelial cell interaction in vitro. Exp Cell Res (1997) 0.93
Urine protein 1: a sex-dependent marker of tubular or glomerular dysfunction. Clin Chem (1989) 0.92
[The French linguistic validation of the Ureteric Stent Symptom Questionnaire (USSQ)]. Prog Urol (2009) 0.92
Alignment of glial cells stimulates directional neurite growth of CNS neurons in vitro. Neuroscience (2004) 0.92
Is fractal geometry useful in medicine and biomedical sciences? Med Hypotheses (2000) 0.91
Altered expression of angiogenesis and lymphangiogenesis markers in the uninvolved skin of plaque-type psoriasis. Br J Dermatol (2008) 0.91
3-Bromophenyl 6-acetoxymethyl-2-oxo-2H-1-benzopyran-3-carboxylate inhibits cancer cell invasion in vitro and tumour growth in vivo. Br J Cancer (2003) 0.89
The metalloproteinase ADAM-12 regulates bronchial epithelial cell proliferation and apoptosis. Cell Prolif (2008) 0.88
Crystal structure of the catalytic domain of MMP-16/MT3-MMP: characterization of MT-MMP specific features. J Mol Biol (2004) 0.88
Whole slide quantification of stromal lymphatic vessel distribution and peritumoral lymphatic vessel density in early invasive cervical cancer: a method description. ISRN Obstet Gynecol (2011) 0.87
Murine 5T multiple myeloma cells induce angiogenesis in vitro and in vivo. Br J Cancer (2002) 0.87
Dialogue between blastocyst hCG and endometrial LH/hCG receptor: which role in implantation? Gynecol Obstet Invest (2007) 0.86
Haemoglobin oxygen affinity and regulating factors of the blood oxygen transport in canine and feline blood. Res Vet Sci (2004) 0.86
[CyberKnife robotic stereotactic radiotherapy: technical aspects and medical indications]. Cancer Radiother (2007) 0.86
Nuclear delivery of a therapeutic peptide by long circulating pH-sensitive liposomes: benefits over classical vesicles. Int J Pharm (2011) 0.85
[Anemia prevalence in pregnant and breast-feeding women in Lubumbashi (Democratic Republic of the Congo). Impact of malaria and intestinal helminthiasis]. J Gynecol Obstet Biol Reprod (Paris) (2003) 0.85
The IGF system in in-vitro human decidualization. Mol Hum Reprod (2008) 0.85
Dosimetric consequences of breath-hold respiration in conformal radiotherapy of esophageal cancer. Phys Med (2007) 0.85
Stromelysin-3 in the biology of the normal and neoplastic mammary gland. J Mammary Gland Biol Neoplasia (1996) 0.84
Aberrant dendritic cell function conditions Th2-cell polarization in allergic rhinitis. Allergy (2013) 0.83
Progression in MCF-7 breast cancer cell tumorigenicity: compared effect of FGF-3 and FGF-4. Breast Cancer Res Treat (2000) 0.83
Development of an animal experimental model to study the effects of levonorgestrel on the human endometrium. Hum Reprod (2008) 0.83
Evaluation of in vitro reconstituted basement membrane assay to assess the invasiveness of tumor cells. Invasion Metastasis (1992) 0.83
Effects of hyperchloremia on blood oxygen binding in healthy calves. J Appl Physiol (1985) (1998) 0.82
In vitro effects of estetrol on receptor binding, drug targets and human liver cell metabolism. Climacteric (2008) 0.82
Purification of active matrix metalloproteinase catalytic domains and its use for screening of specific stromelysin-3 inhibitors. Protein Expr Purif (1999) 0.82
Production and activation of matrix metalloprotease-9 (MMP-9) by HL-60 promyelocytic leukemia cells. Biochem Biophys Res Commun (1997) 0.82
High frequency of RASSF1A and RARb2 gene promoter methylation in morphologically normal endometrium adjacent to endometrioid adenocarcinoma. Histopathology (2008) 0.82
Cyclodextrins as a potential carrier in drug nebulization. J Control Release (2004) 0.81
[Statistical process control applied to intensity modulated radiotherapy pretreatment controls with portal dosimetry]. Cancer Radiother (2010) 0.81
Curcumin-cyclodextrin complexes potentiate gemcitabine effects in an orthotopic mouse model of lung cancer. Br J Cancer (2012) 0.81
Comparative study of the oxyhaemoglobin dissociation curve of four mammals: man, dog, horse and cattle. Comp Biochem Physiol Comp Physiol (1993) 0.81
[Five years follow-up of infections with extended-spectrum beta-lactamase producing enterobacteriaceae]. Prog Urol (2011) 0.81
Cloning of choriocarcinoma cells shows that invasion correlates with expression and activation of gelatinase A. Exp Cell Res (1996) 0.81
Impact of emerging pollutants on pulmonary inflammation in asthmatic rats: ethanol vapors and agglomerated TiO2 nanoparticles. Inhal Toxicol (2012) 0.80
[What is the publication rate of papers presented at the French Association of Urology annual conferences?]. Prog Urol (2008) 0.80
Evidence of a limited contribution of feto-maternal interactions to trophoblast differentiation along the invasive pathway. Tissue Antigens (2003) 0.80
Impaired ICOSL in human myeloid dendritic cells promotes Th2 responses in patients with allergic rhinitis and asthma. Clin Exp Allergy (2014) 0.80
Mixed origin of neovascularization of human endometrial grafts in immunodeficient mouse models. Hum Reprod (2009) 0.80
Long-term outcomes of 80-watt KTP and 120-watt HPS GreenLight photoselective vaporization of the prostate. Urol Int (2014) 0.79
Reestimation of the effects of inorganic phosphates on the equilibrium between oxygen and hemoglobin. Intensive Care Med (1992) 0.79
Expression of stromelysin-3 in the human placenta and placental bed. Placenta (1997) 0.79
[Extragenital endometriosis]. J Gynecol Obstet Biol Reprod (Paris) (2007) 0.79
Anti-A isoagglutinins and pneumococcal vaccine. Lancet (1981) 0.79
[Short or long schemes of antibiotic prophylaxis for prostate biopsy. A multicentre prospective randomised study]. Prog Urol (2008) 0.79
[Metabolic syndrome and urinary disorders]. Prog Urol (2012) 0.79
[Role of plasminogen activator inhibitor type 1 in tumor angiogenesis]. Therapie (2002) 0.79
Preparation of macroporous biodegradable poly(L-lactide-co-epsilon-caprolactone) foams and characterization by mercury intrusion porosimetry, image analysis, and impedance spectroscopy. J Biomed Mater Res A (2003) 0.79
Paradoxical stimulation of matrix metalloproteinase-9 expression in HT1080 cells by a broad-spectrum hydroxamate-based matrix metalloproteinase inhibitor. Ann N Y Acad Sci (1999) 0.78
[Influence of HIV-1 and placental malaria co-infection on newborn biometry and Apgar scores in Kinshasa, Democratic Republic of Congo]. J Gynecol Obstet Biol Reprod (Paris) (2011) 0.78
Complications following definitive irradiation for cancers of the oral cavity and the oropharynx (in a series of 1134 patients). Int J Radiat Oncol Biol Phys (1997) 0.78
A molecular biologic study of extracellular matrix components during the development of glomerulosclerosis in murine chronic graft-versus-host disease. Lab Invest (1992) 0.78
[Ureteral stenosis after renal transplantation: Risk factors and impact on survival]. Prog Urol (2011) 0.78
Sensitizing human cervical cancer cells In vitro to ionizing radiation with interferon beta or gamma. Radiat Res (1999) 0.78
[The non-hormonal treatment of metastatic prostate cancer]. Prog Urol (2013) 0.78